Selected research
Industry Growth & Trends
Global Gadolinium-Based Contrast Agents Industry Growth and Trends Forecast to 2032
Market perspective
The global Gadolinium-Based Contrast Agents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Gadolinium-Based Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Gadolinium-Based Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gadolinium-Based Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Gadolinium-Based Contrast Agents include Agfa, BeiLu Pharma, Bracco Imaging, GE Healthcare, Guerbet Group, Hengrui Medicine, Lantheus, Marotrast and YRPG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Gadolinium-Based Contrast Agents market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Gadolinium-Based Contrast Agents market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gadolinium-Based Contrast Agents market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gadolinium-Based Contrast Agents.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Gadolinium-Based Contrast Agents market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Gadolinium-Based Contrast Agents Market by Company
Agfa
BeiLu Pharma
Bracco Imaging
GE Healthcare
Guerbet Group
Hengrui Medicine
Lantheus
Marotrast
YRPG
Bayer
Jiangsu Hengrui Medicine
Stary
Gadolinium-Based Contrast Agents Segment by Type
Linear Gadolinium-Based Contrast Agents
Macrocycle Gadolinium-Based Contrast Agents
Gadolinium-Based Contrast Agents Segment by Application
Hospital
Specialist Clinic
Others
Gadolinium-Based Contrast Agents Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadolinium-Based Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gadolinium-Based Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadolinium-Based Contrast Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gadolinium-Based Contrast Agents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Gadolinium-Based Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Linear Gadolinium-Based Contrast Agents
- Macrocycle Gadolinium-Based Contrast Agents
Applications
- Hospital
- Specialist Clinic
- Others
Companies covered
- Agfa
- BeiLu Pharma
- Bracco Imaging
- GE Healthcare
- Guerbet Group
- Hengrui Medicine
- Lantheus
- Marotrast
- YRPG
- Bayer
- Jiangsu Hengrui Medicine
- Stary
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Gadolinium-Based Contrast Agents Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Gadolinium-Based Contrast Agents Sales Estimates and Forecasts (2021-2032)
- 1.3 Gadolinium-Based Contrast Agents Market by Type
- 1.3.1 Linear Gadolinium-Based Contrast Agents
- 1.3.2 Macrocycle Gadolinium-Based Contrast Agents
- 1.4 Global Gadolinium-Based Contrast Agents Market Size by Type
- 1.4.1 Global Gadolinium-Based Contrast Agents Market Size Overview by Type (2021-2032)
- 1.4.2 Global Gadolinium-Based Contrast Agents Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Gadolinium-Based Contrast Agents Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Gadolinium-Based Contrast Agents Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Gadolinium-Based Contrast Agents Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Gadolinium-Based Contrast Agents Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Gadolinium-Based Contrast Agents Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Gadolinium-Based Contrast Agents Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Gadolinium-Based Contrast Agents Industry Trends
- 2.2 Gadolinium-Based Contrast Agents Industry Drivers
- 2.3 Gadolinium-Based Contrast Agents Industry Opportunities and Challenges
- 2.4 Gadolinium-Based Contrast Agents Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Gadolinium-Based Contrast Agents Revenue (2021-2026)
- 3.2 Global Top Players by Gadolinium-Based Contrast Agents Sales (2021-2026)
- 3.3 Global Top Players by Gadolinium-Based Contrast Agents Price (2021-2026)
- 3.4 Global Gadolinium-Based Contrast Agents Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Gadolinium-Based Contrast Agents Major Company Production Sites & Headquarters
- 3.6 Global Gadolinium-Based Contrast Agents Company, Product Type & Application
- 3.7 Global Gadolinium-Based Contrast Agents Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Gadolinium-Based Contrast Agents Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Gadolinium-Based Contrast Agents Players Market Share by Revenue in 2025
- 3.8.3 2025 Gadolinium-Based Contrast Agents Tier 1, Tier 2, and Tier 3
4 Gadolinium-Based Contrast Agents Regional Status and Outlook
- 4.1 Global Gadolinium-Based Contrast Agents Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Gadolinium-Based Contrast Agents Historic Market Size by Region
- 4.2.1 Global Gadolinium-Based Contrast Agents Sales in Volume by Region (2021-2026)
- 4.2.2 Global Gadolinium-Based Contrast Agents Sales in Value by Region (2021-2026)
- 4.2.3 Global Gadolinium-Based Contrast Agents Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Gadolinium-Based Contrast Agents Forecasted Market Size by Region
- 4.3.1 Global Gadolinium-Based Contrast Agents Sales in Volume by Region (2027-2032)
- 4.3.2 Global Gadolinium-Based Contrast Agents Sales in Value by Region (2027-2032)
- 4.3.3 Global Gadolinium-Based Contrast Agents Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gadolinium-Based Contrast Agents by Application
- 5.1 Gadolinium-Based Contrast Agents Market by Application
- 5.1.1 Hospital
- 5.1.2 Specialist Clinic
- 5.1.3 Others
- 5.2 Global Gadolinium-Based Contrast Agents Market Size by Application
- 5.2.1 Global Gadolinium-Based Contrast Agents Market Size Overview by Application (2021-2032)
- 5.2.2 Global Gadolinium-Based Contrast Agents Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Gadolinium-Based Contrast Agents Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Gadolinium-Based Contrast Agents Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Gadolinium-Based Contrast Agents Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Gadolinium-Based Contrast Agents Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Gadolinium-Based Contrast Agents Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Gadolinium-Based Contrast Agents Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Agfa
- 6.1.1 Agfa Company Information
- 6.1.2 Agfa Business Overview
- 6.1.3 Agfa Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Agfa Gadolinium-Based Contrast Agents Product Portfolio
- 6.1.5 Agfa Recent Developments
- 6.2 BeiLu Pharma
- 6.2.1 BeiLu Pharma Company Information
- 6.2.2 BeiLu Pharma Business Overview
- 6.2.3 BeiLu Pharma Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 BeiLu Pharma Gadolinium-Based Contrast Agents Product Portfolio
- 6.2.5 BeiLu Pharma Recent Developments
- 6.3 Bracco Imaging
- 6.3.1 Bracco Imaging Company Information
- 6.3.2 Bracco Imaging Business Overview
- 6.3.3 Bracco Imaging Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Bracco Imaging Gadolinium-Based Contrast Agents Product Portfolio
- 6.3.5 Bracco Imaging Recent Developments
- 6.4 GE Healthcare
- 6.4.1 GE Healthcare Company Information
- 6.4.2 GE Healthcare Business Overview
- 6.4.3 GE Healthcare Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 GE Healthcare Gadolinium-Based Contrast Agents Product Portfolio
- 6.4.5 GE Healthcare Recent Developments
- 6.5 Guerbet Group
- 6.5.1 Guerbet Group Company Information
- 6.5.2 Guerbet Group Business Overview
- 6.5.3 Guerbet Group Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Guerbet Group Gadolinium-Based Contrast Agents Product Portfolio
- 6.5.5 Guerbet Group Recent Developments
- 6.6 Hengrui Medicine
- 6.6.1 Hengrui Medicine Company Information
- 6.6.2 Hengrui Medicine Business Overview
- 6.6.3 Hengrui Medicine Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio
- 6.6.5 Hengrui Medicine Recent Developments
- 6.7 Lantheus
- 6.7.1 Lantheus Company Information
- 6.7.2 Lantheus Business Overview
- 6.7.3 Lantheus Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Lantheus Gadolinium-Based Contrast Agents Product Portfolio
- 6.7.5 Lantheus Recent Developments
- 6.8 Marotrast
- 6.8.1 Marotrast Company Information
- 6.8.2 Marotrast Business Overview
- 6.8.3 Marotrast Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Marotrast Gadolinium-Based Contrast Agents Product Portfolio
- 6.8.5 Marotrast Recent Developments
- 6.9 YRPG
- 6.9.1 YRPG Company Information
- 6.9.2 YRPG Business Overview
- 6.9.3 YRPG Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 YRPG Gadolinium-Based Contrast Agents Product Portfolio
- 6.9.5 YRPG Recent Developments
- 6.10 Bayer
- 6.10.1 Bayer Company Information
- 6.10.2 Bayer Business Overview
- 6.10.3 Bayer Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Bayer Gadolinium-Based Contrast Agents Product Portfolio
- 6.10.5 Bayer Recent Developments
- 6.11 Jiangsu Hengrui Medicine
- 6.11.1 Jiangsu Hengrui Medicine Company Information
- 6.11.2 Jiangsu Hengrui Medicine Business Overview
- 6.11.3 Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio
- 6.11.5 Jiangsu Hengrui Medicine Recent Developments
- 6.12 Stary
- 6.12.1 Stary Company Information
- 6.12.2 Stary Business Overview
- 6.12.3 Stary Gadolinium-Based Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Stary Gadolinium-Based Contrast Agents Product Portfolio
- 6.12.5 Stary Recent Developments
7 North America by Country
- 7.1 North America Gadolinium-Based Contrast Agents Sales by Country
- 7.1.1 North America Gadolinium-Based Contrast Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Gadolinium-Based Contrast Agents Sales by Country (2021-2026)
- 7.1.3 North America Gadolinium-Based Contrast Agents Sales Forecast by Country (2027-2032)
- 7.2 North America Gadolinium-Based Contrast Agents Market Size by Country
- 7.2.1 North America Gadolinium-Based Contrast Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Gadolinium-Based Contrast Agents Market Size by Country (2021-2026)
- 7.2.3 North America Gadolinium-Based Contrast Agents Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Gadolinium-Based Contrast Agents Sales by Country
- 8.1.1 Europe Gadolinium-Based Contrast Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Gadolinium-Based Contrast Agents Sales by Country (2021-2026)
- 8.1.3 Europe Gadolinium-Based Contrast Agents Sales Forecast by Country (2027-2032)
- 8.2 Europe Gadolinium-Based Contrast Agents Market Size by Country
- 8.2.1 Europe Gadolinium-Based Contrast Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Gadolinium-Based Contrast Agents Market Size by Country (2021-2026)
- 8.2.3 Europe Gadolinium-Based Contrast Agents Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Gadolinium-Based Contrast Agents Sales by Country
- 9.1.1 Asia-Pacific Gadolinium-Based Contrast Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Gadolinium-Based Contrast Agents Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Gadolinium-Based Contrast Agents Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Gadolinium-Based Contrast Agents Market Size by Country
- 9.2.1 Asia-Pacific Gadolinium-Based Contrast Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Gadolinium-Based Contrast Agents Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Gadolinium-Based Contrast Agents Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Gadolinium-Based Contrast Agents Sales by Country
- 10.1.1 South America Gadolinium-Based Contrast Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Gadolinium-Based Contrast Agents Sales by Country (2021-2026)
- 10.1.3 South America Gadolinium-Based Contrast Agents Sales Forecast by Country (2027-2032)
- 10.2 South America Gadolinium-Based Contrast Agents Market Size by Country
- 10.2.1 South America Gadolinium-Based Contrast Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Gadolinium-Based Contrast Agents Market Size by Country (2021-2026)
- 10.2.3 South America Gadolinium-Based Contrast Agents Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Gadolinium-Based Contrast Agents Sales by Country
- 11.1.1 Middle East and Africa Gadolinium-Based Contrast Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Gadolinium-Based Contrast Agents Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Gadolinium-Based Contrast Agents Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Gadolinium-Based Contrast Agents Market Size by Country
- 11.2.1 Middle East and Africa Gadolinium-Based Contrast Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Gadolinium-Based Contrast Agents Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Gadolinium-Based Contrast Agents Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Gadolinium-Based Contrast Agents Value Chain Analysis
- 12.1.1 Gadolinium-Based Contrast Agents Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Gadolinium-Based Contrast Agents Production Mode & Process
- 12.2 Gadolinium-Based Contrast Agents Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Gadolinium-Based Contrast Agents Distributors
- 12.2.3 Gadolinium-Based Contrast Agents Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst